IN3 Summit Will Offer Partnering Opportunities for Medtech Innovators with Top Investors & Corporate Acquirers in San Francisco on October 27-29, 2010


For complete details or to register, visit www.IN3Summit.com.


Flexible Pricing is Still Available – Call for Select Discounts!
+1-949-453-0071


The medtech industry’s leading conference for face-to-face dialogue with top investors, large device companies, and the hottest emerging innovators.


* Robust program with more than 30 investors & industry leaders scheduled to present.


* 35+ emerging innovators expected – Only 4 speaking slots remaining – Apply to Present now!


* “Medtech Risk Capital? Anything But. A VC Roundtable from IN3”

(Start-Up Magazine, Sept. 2010) DOWNLOAD THIS COMPLIMENTARY ARTICLE


* Download current event brochure + more.


At IN3 Summit, get all the latest news from these key sessions:


“What Are Corporate Buyers Looking For?”


* David Cassak, Vice President, Content, Elsevier Business Intelligence (moderator)

* Jeffrey J. Steinle, Sr. Director, Corporate Development, Medtronic

* Lukas Scheibler, PhD, Vice President, R & D Alliances, Alcon Laboratories, Inc.


“What Are the Hot Deals Now and in the Future?”

* David Cassak, Vice President, Content, Elsevier Business Intelligence (moderator)

* John Onopchenko, Managing Director, Synergy LSP

* Jeani Delagardelle, Managing Director, New Leaf Ventures

* Evan Melrose, Managing Director, PTV Sciences

* Lisa Suennen, Co-founder and Managing Member, Psilos

* Teo Forcht Dagi, MD, MPH, Partner, HLM Venture Partners


“Changes to the 510(k) Program: New Requirements You Must Implement.”

* David Filmore, Senior Editor of “The Gray Sheet” (moderator) – Elsevier Business Intelligence

* Christy Foreman, Acting Director of the Office of Device Evaluation – CDRH, FDA

* Dr. Joshua Makower, Founder/CEO, ExploraMed, Inc.

* Laurie Clarke, Partner, King & Spaulding, LLP


The comments are closed.